Consumer Defensive
Skinvisible, Inc.(SKVI)
Live Price
Offline$0.2126
+0.00% today
1Y Change
-20.37%
Window
Jun 23, 2025 โ Jun 16, 2026
- Market Cap
- โ
- Revenue Growth
- 0.0%
- EPS Growth
- -81.8%
- Dividend Yield
- 0.0%
Coverage: 252 bars ยท Jun 23, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Skinvisible, Inc. (SKVI) is a Consumer Defensive stock with listed on OTC. The stock last traded around $0.21 and down 20.4% across the available one-year price window (Jun 23, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -81.8%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -81.8%, free cash flow -48588171.0% with operating margin -2481.6% and ROIC 0.0%. Valuation already assumes a fairly strong business story at price/sales 67.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SKVI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
0.0% vs +1.7% peer median
Operating Margin
Below sector median
-2481.6% vs +6.6% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 13, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at 0.0% and EPS is at -81.8%, with operating margin around -2481.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.1% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 13, 2026 | โ | +0.0% | -10.7% | +10.9% |
2026 Mar 31, 2026 | โ | +0.0% | +34.9% | +26.5% |
2025 Nov 13, 2025 | โ | +14.9% | -23.9% | -7.2% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SKVI
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SKVI Max Drawdown
-73.64%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SKVI and SPY.
Company Overview
Skinvisible, Inc.
Other OTC
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over the counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company offers sunless tanning and sunscreen products under the Skinbrella name. It also licenses to pharmaceutical and consumer goods companies; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada.
- Leadership
- Terry H. Howlett
- IPO Date
- Jan 11, 1999
- Employees
- 2
- Street Address
- 6320 South Sandhill Road
- Mailing
- Las Vegas, NV, 89120
- Region
- Las Vegas, NV, US
- Reporting Currency
- USD
- Investor Line
- 702 433 7154
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 67.5
- Price/Book
- โ
Growth
- Revenue
- 0.0%
- EPS
- -81.8%
- Free Cash Flow
- -48588171.0%
Profitability
- Gross Margin
- -1.2%
- Operating Margin
- -2481.6%
- Net Margin
- -5320.2%
- ROE
- 0.0%
- ROIC
- 0.0%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.01
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.